Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Cantor Fitzgerald

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201746

« Back to Dashboard

NDA 201746 describes LINCOMYCIN, which is a drug marketed by X-gen Pharms Inc and Watson Labs and is included in two NDAs. It is available from one supplier. Additional details are available on the LINCOMYCIN profile page.

The generic ingredient in LINCOMYCIN is lincomycin hydrochloride. There are ten drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the lincomycin hydrochloride profile page.

Summary for 201746

Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 201746

Suppliers and Packaging for NDA: 201746

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LINCOMYCIN lincomycin hydrochloride INJECTABLE;INJECTION 201746 ANDA X-GEN Pharmaceuticals, Inc. 39822-0350 39822-0350-2 10 VIAL in 1 CARTON (39822-0350-2) > 2 mL in 1 VIAL (39822-0350-1)
LINCOMYCIN lincomycin hydrochloride INJECTABLE;INJECTION 201746 ANDA X-GEN Pharmaceuticals, Inc. 39822-0353 39822-0353-6 10 mL in 1 VIAL (39822-0353-6)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 300MG BASE/ML
Approval Date:Jun 4, 2015TE:APRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Harvard Business School
Daiichi Sankyo
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: